Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection

Journal of Clinical Oncology

Volumn 22, Issue 16, 2004, Pages 3255-3260

  Downey, Robert J ^a   Akhurst, Timothy ^a   Gonen, Mithat ^a   Vincent, Alain ^a   Bains, Manjit S ^a   Larson, Steven ^a   Rusch, Valerie ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TUMOR VOLUME; ADULT; AGED; ARTICLE; CARCINOID; COMPUTER ASSISTED EMISSION TOMOGRAPHY; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ADULT; AGED; CARCINOID TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 4344714364     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.11.109     Document Type: Review

References (18)

1. Reed CE, Harpole DH, Posther KE, et al: Results of the American College of Surgeons Oncology Group (ACOSOG) Z0050 Trial: The utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126:1943-1951, 2003
2. Duhaylongsod FG, Lowe VJ, Patz EF Jr, et al: Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 110:130-139, 1995
3. Vesselle H, Schmidt RA, Pugsley JM, et al: Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6:3837-3844, 2000
4. Vesselle H, Grierson J, Muzi M, et al: In vivo validation of 3′deoxy-3-[(18)F]fluorothymidine ([18)F]FLT) as a proliferation imaging tracer in humans: Correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin Cancer Res 8:3315-3323, 2002
5. Arai T, Kuroishi T, Saito Y, et al: Tumor doubling time and prognosis in lung cancer patients: Evaluation from chest films and clinical follow-up study - Japanese Lung Cancer Screening Research Group. Jpn J Clin Oncol 24:199-204, 1994
6. Usuda K, Saito Y, Sagawa M, et al: Tumor doubling time and prognostic assessment of patient with primary lung cancer. Cancer 74:2239-2244, 1994
7. Tirindelli-Danesi D, Teodori L, Mauro F, et al: Prognostic significance of flow cytometry in lung cancer: A 5-year study. Cancer 60:844-851, 1987
8. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 111:1710-1717, 1997
9. Grambsch PM, Therneau TM: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515-526, 1994
10. Rosell R, Gomez-Condina J, Camps C, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330:153-158, 1994
11. Roth JA, Fossella F, Komaki R, et al: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 86:673-680, 1994
12. Pisters KM, Ginsberg RJ, Giroux DJ, et al: Induction chemotherapy before surgery for early-stage lung cancer: A novel approach - Bimodality Lung Cancer Oncology Team. J Thorac Cardiovasc Surg 119:429-439, 2000
13. Nonaka M, Kadokura M, Yamamoto S, et al: Tumor dimension and prognosis in surgically treated lung cancer: For intentional limited resection. Am J Clin Oncol 26:499-503, 2003
14. Ahuja V, Coleman RD, Herndon J, et al: The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung cancer. Cancer 83:918-924, 1998
15. Vansteenkiste JF, Stroobants SG, Dupont PF, et al: Prognostic importance of the standardized uptake value on (18) F-fluoro-2-deoxyglucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases - Leuven Lung Cancer Group. J Clin Oncol 17:3201-3206, 1999
16. Dhital K, Saunders CA, Seed PT, et al: [(18)F] fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg 18:425-428, 2000
17. Higashi K, Ueda Y, Arisaka Y, et al: 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 43:39-45, 2002
18. Jeong HJ, Min JJ, Park JM, et al: Determination of the prognostic value of [(18)F] fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun 23:865-870, 2002